Dr. Jason A. Konner

Dr. Jason A. Konner, MD, is a highly regarded medical oncologist specializing in the treatment of gynecologic malignancies, including ovarian, uterine, and cervical cancers. He serves as an attending physician at Memorial Sloan Kettering Cancer Center and holds a faculty position at Weill Cornell Medical College. Dr. Konner earned his medical degree from Stanford University School of Medicine and completed his residency in internal medicine at The Mount Sinai Hospital. He later pursued a fellowship in hematology and medical oncology at Memorial Sloan Kettering. Board-certified in medical oncology and internal medicine, Dr. Konner has dedicated his career to the care of women with complex gynecologic cancers and the development of novel therapeutic strategies.

A leader in early-phase clinical research, Dr. Konner has been instrumental in the design and execution of trials that have shaped the standard of care for patients with treatment-resistant gynecologic cancers. His research interests focus on the integration of targeted therapies and immunotherapies, particularly for platinum-resistant ovarian cancer. He has led pivotal studies on antibody-drug conjugates and immuno-oncology combinations, contributing to the development of drugs like mirvetuximab soravtansine. His work has been published in top-tier oncology journals and continues to inform innovative treatment pathways for women facing advanced or rare gynecologic tumors.

In addition to his clinical and research expertise, Dr. Konner is a committed educator and mentor, training fellows and junior investigators in the intricacies of clinical oncology and trial development. He is actively involved in professional organizations such as the Society of Gynecologic Oncology and the American Society of Clinical Oncology, where he contributes to the advancement of gynecologic oncology through committee work and academic collaboration. Through his dedication to patient-centered care, translational research, and professional mentorship, Dr. Konner stands as a respected figure in the ongoing pursuit of excellence in women’s cancer care.